Ishipar Oral Suspension contains Paracetamol 250mg per 5ml, a widely used analgesic and antipyretic agent indicated for the relief of mild to moderate pain and fever reduction. Paracetamol acts centrally in the brain to inhibit prostaglandin synthesis, thereby alleviating pain and lowering elevated body temperature. Ishipar Oral Suspension is commonly prescribed for pediatric patients due to its convenient liquid form, facilitating accurate dosing and ease of administration in children who have difficulty swallowing tablets. It is effective in managing conditions such as headache, toothache, musculoskeletal pain, and febrile illnesses including common cold and influenza. The suspension should be administered according to the recommended dosage based on the patient’s age and weight to avoid the risk of hepatotoxicity associated with overdose. It is contraindicated in patients with known hypersensitivity to paracetamol or any of the formulation’s excipients. Caution is advised in individuals with pre-existing liver impairment or chronic alcohol use. Ishipar Oral Suspension is generally well tolerated when used as directed, with adverse effects being rare but potentially including allergic reactions or skin rashes. Consultation with a healthcare professional is recommended before use, especially in cases of prolonged fever or persistent pain.